[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364415-105":59,"doc-detail-364415-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","primary-squamous-cell-carcinoma-in-a-transplanted-kidney-a-unique-case-highlighting-challenges-in-diagnosis-and-management","Primary Squamous Cell Carcinoma in a Transplanted Kidney - A Unique Case Highlighting Challenges in Diagnosis and Management","","Kidney transplantation remains the preferred option for end-stage renal disease, yet it carries a malignancy risk influenced by multiple factors. The article reports a rare case of primary renal squamous cell carcinoma (SCC) developing in an allograft kidney one year after transplant. The patient presented with oliguria, elevated creatinine, and asthenia; imaging suggested a mass and biopsy confirmed primary SCC, prompting nephrectomy and hemodialysis. The report reviews diagnostic uncertainty, immunosuppression-related cancer risk, and possible imaging and laboratory surveillance strategies to support long-term graft health.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/primary-squamous-cell-carcinoma-in-a-transplanted-kidney-a-unique-case-highlighting-challenges-in-diagnosis-and-management/364415/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/primary-squamous-cell-carcinoma-in-a-transplanted-kidney-a-unique-case-highlighting-challenges-in-diagnosis-and-management/364415.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",18,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What diagnosis was confirmed in the transplanted kidney, and how was it confirmed?","Question",{"text":113,"@type":114},"A primary renal squamous cell carcinoma (SCC) in the allograft kidney was confirmed. Imaging raised suspicion for a mass, and subsequent biopsy confirmed SCC.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why are transplant recipients at higher risk of malignancy?",{"text":118,"@type":114},"The article notes increased cancer risk tied to multiple variables, especially lifelong immunosuppressive therapy needed to prevent rejection. These medications can promote oncogenesis.",{"name":120,"@type":111,"acceptedAnswer":121},"What clinical presentation led to further evaluation in this case?",{"text":122,"@type":114},"The patient presented with oliguria (decreased urine output) and dark urine, along with elevated creatinine and asthenia, prompting imaging and biopsy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},364415,1790646721,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":105,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Review began 12/24/2024  \nReview ended 01/07/2025  \nPublished 01/08/2025  \n© Copyright 2025  \nPagan Santini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CCBY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.77154  \nOpen Access Case Report  \nPrimary Squamous Cell Carcinoma in a Transplanted Kidney: A Unique Case Highlighting Challenges in Diagnosis and Management  \nRicardo A. Pagan Santini 1 , Madhu Bhaskaran 2 , Vinay Nair 3, Gayatri Nair 3, Ahmed Fahmy 4  \n1. Department of Internal Medicine, Long Island Jewish Forest Hills, Northwell Health, New York, USA 2. Department of Nephrology and Transplant Nephrology, Northwell Health, New York, USA 3. Department of Nephrology, Division of Transplant Surgery, Northwell Health, New York, USA 4. Department of Surgery, Division of Transplant Surgery, Northwell Health, New York, USA  \nCorresponding author: Ricardo A. Pagan Santini, [rpagansantini@northwell.edu](rpagansantini@northwell.edu)  \nAbstract  \nKidney transplantation is the preferred treatment for end-stage renal disease, but it involves risks, including an increased chance of malignancy due to several variables. We present a rare case of primary renal squamous cell carcinoma (SCC) in an allograft kidney. This patient, who had a renal transplant one year prior, presented with oliguria, elevated creatinine, and asthenia. Imaging done raised suspicion of a masslike structure and biopsy subsequently done confirmed a primary SCC in the transplanted kidney, leading toa total nephrectomy and hemodialysis initiation. This case highlights the different cancer risks faced by transplant recipients, particularly due to immunosuppressive medications. We discuss emerging alternativesin immunosuppression that may mitigate these risks. Given the rarity of primary SCC in allografts, determining the cancer’s origin whether primary or metastatic is critical for effective management since this distinction could shape future approaches to managing allograft malignancies. We also emphasize the importance of establishing imaging and monitoring guidelines and how combining imaging with serum and urine studies may enhance cancer surveillance, aiding in long-term graft health and transplant longevity.  \nCategories: Nephrology, Transplantation  \nKeywords: cancer surveillance, immuno suppression, nephrololgy, renal allograft, renal squamous cell carcinoma,  \nrenal transplant, squamous cell carcinoma (scc)  \nIntroduction  \nKidney transplants have become a critical area of research in nephrology over the past years since they are the preferred treatment for end-stage renal disease. However, transplants are still associated with persistent complications, one of the most concerning being malignancy. While skin cancers are the most reported posttransplant malignancies, there are rare occurrences of allograft tumors, such as renal cell carcinoma and papillomas originating within the kidney tissue itself [1] . In this report, we present a rare case of primary renal squamous cell carcinoma (SCC) occurring in an allograft kidney. Although risk factors contributing to renal SCC are well-documented, these cases have been identified in native kidneys rather than in transplanted organs, making this instance particularly unique [1] . Another significant factor contributing to malignancy in kidney transplant recipients is the lifelong use of immunosuppressive therapy. These medications are necessary to prevent organ rejection but come with the downside of increasing cancer risk  \n[1] . This discussion will cover the mechanisms by which commonly used immunosuppressive drugs promote oncogenesis, as well as explore newer agents that aim to mitigate these risks while still being effective for transplant recipients. Additionally, we highlight the limitations of current screening guidelines, emphasizi","cbCaifmXr0IRdsFc","https://ap.wps.com/l/cbCaifmXr0IRdsFc","pdf",4422034,"English","# Abstract\n# Introduction\n# Case Presentation\n# How to Cite","[{\"question\":\"What diagnosis was confirmed in the transplanted kidney, and how was it confirmed?\",\"answer\":\"A primary renal squamous cell carcinoma (SCC) in the allograft kidney was confirmed. Imaging raised suspicion for a mass, and subsequent biopsy confirmed SCC.\"},{\"question\":\"Why are transplant recipients at higher risk of malignancy?\",\"answer\":\"The article notes increased cancer risk tied to multiple variables, especially lifelong immunosuppressive therapy needed to prevent rejection. These medications can promote oncogenesis.\"},{\"question\":\"What clinical presentation led to further evaluation in this case?\",\"answer\":\"The patient presented with oliguria (decreased urine output) and dark urine, along with elevated creatinine and asthenia, prompting imaging and biopsy.\"}]","Primary Squamous Cell Carcinoma in a Transplanted Kidney - A Unique Case Highlighting Challenges in Diagnosis and Management | PDF",1790157486,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d42de9b0790b430458f5b635c5ddf83.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1c7f7f0b052d2f450804e08e9194960.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05a75c6d144e1f1355c008813660c943.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f29097b0fb1d51c83e870a72c2ab581.webp",980,1386]